CognitiveCoefficient
Detail
Join free

Albert Bourla

All people
Influence report · generated from Albert Bourla's indicators

Albert Bourla, full AI read

Albert Bourla, Chairman & CEO, Pfizer (United States), ranks #363/500 on the Power & Influence Index (46.4). Entrenchment 64/100.

Role
Chairman & CEO, Pfizer
Country
United States
Category
Industry & energy
Net worth / capital
-
Controls
Pharmaceuticals, vaccines, mRNA

Dimension read

DimensionValueStandingWhat a high vs low value means, and where Albert Bourla sits
PII Power & Influence (PII)46.4Moderate · #363/635Mid-pack. High would mean near the apex of civilizational influence; low would mean lower relative influence within this elite set.
▲ high: near the apex of civilizational influence  ·  ▼ low: lower relative influence within this elite set
Economic power Economic power58.0Moderate · #326/635Mid-pack. High would mean controls vast wealth and companies; low would mean limited economic control.
▲ high: controls vast wealth and companies  ·  ▼ low: limited economic control
Political power Political power54.0Moderate · #260/635Mid-pack. High would mean commands states, law or policy; low would mean little formal political power.
▲ high: commands states, law or policy  ·  ▼ low: little formal political power
AI power AI power34.0Moderate · #378/635Mid-pack. High would mean shapes or controls the trajectory of AI; low would mean limited sway over AI's direction.
▲ high: shapes or controls the trajectory of AI  ·  ▼ low: limited sway over AI's direction
Platform reach Platform reach48.0Moderate · #367/635Mid-pack. High would mean commands a vast audience or network; low would mean limited direct reach.
▲ high: commands a vast audience or network  ·  ▼ low: limited direct reach
Institutional control Institutional control62.0Moderate · #397/635Mid-pack. High would mean controls pivotal institutions and capital; low would mean limited institutional control.
▲ high: controls pivotal institutions and capital  ·  ▼ low: limited institutional control
Entrenchment / tenure Entrenchment / tenure64.0Moderate · #296/635Mid-pack. High would mean power is locked in (indefinite or controlling stake); low would mean power is contingent, term-limited or contestable.
▲ high: power is locked in (indefinite or controlling stake)  ·  ▼ low: power is contingent, term-limited or contestable

Strengths

  • No standout dimension.

Risk factors

  • Significant but balanced influence with no single dominant lever.
These are model outputs and scenarios, not forecasts of actual outcomes. This platform measures access to, utilization of, and leverage from cognitive infrastructure, not intelligence. No causality or certainty is claimed.

AI worldview

Optimisticconfidence 0.4

Ideas & positions

Albert Bourla has not made extensive public statements specifically about AI. However, in his role as CEO of Pfizer, he has emphasized the importance of innovation and technology in advancing healthcare solutions. He has supported the use of AI in drug discovery and development processes to accelerate research and improve patient outcomes. Bourla has not publicly taken a stance on existential risk, open vs closed models, or specific regulatory frameworks for AI.

What shapes the view

Bourla's views on AI are likely shaped by his background in pharmaceuticals and his focus on leveraging technology to drive medical advancements. His emphasis on innovation and efficiency suggests a positive outlook on the integration of AI in the healthcare industry. The competitive landscape of the pharmaceutical industry, where rapid development and precision are critical, may also influence his support for AI technologies.

The AI-powered future they see

Bourla predicts that AI will play a significant role in transforming the pharmaceutical industry by enhancing the speed and accuracy of drug development. He promotes the idea that AI can help identify new therapeutic targets and optimize clinical trials, ultimately leading to more effective treatments and better patient care. He has not publicly warned about potential downsides or risks associated with AI in healthcare.

DystopianContingentUtopian
An AI-generated synthesis of the public record (statements, essays, interviews, papers), not statements by the person; positions evolve and the model's knowledge has a cutoff.